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ABSTRACT: Here we communicate the development of a novel multifunctional
hybrid nanomaterial, magnetic carbon nanotubes (CNTs) ensheathed with
mesoporous silica, for the simultaneous applications of drug delivery and imaging.
Magnetic nanoparticles (MNPs) were ﬁrst decorated onto the multiwalled CNTs,
which was then layered with mesoporous silica (mSiO2) to facilitate the loading of
bioactive molecules to a large quantity while exerting magnetic properties. The
hybrid nanomaterial showed a high mesoporosity due to the surface-layered
mSiO2, and excellent magnetic properties, including magnetic resonance imaging
in vitro and in vivo. The mesoporous and magnetic hybrid nanocarriers showed
high loading capacity for therapeutic molecules including drug gentamicin and
protein cytochrome C. In particular, genetic molecule siRNA was eﬀectively
loaded and then released over a period of days to a week. Furthermore, the hybrid
nanocarriers exhibited a high cell uptake rate through magnetism, while eliciting
favorable biological eﬃcacy within the cells. This novel hybrid multifunctional nanocarrier may be potentially applicable as drug
delivery and imaging systems.
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■ INTRODUCTION
Carbon nanotubes (CNTs), ﬁrst discovered in 1991,1 have
found potential applications in a variety of ﬁelds because of
their unique optical, electronic, and mechanical properties.2
Great interests have recently arisen in their biomedical utility,
mainly as a carrier of therapeutic molecules.3−5 Because of their
size in the nanoscale regime, the consequent ultrahigh surface
area, and the possible surface functional group modiﬁcation,
CNTs are an attractive platform for the delivery of drugs and
genes into the target cells. Although concerns of biocompat-
ibility (cell and tissue toxicity) of CNTs have been raised as a
practical issue, and many in-depth studies of this are still
ongoing, it is generally accepted that when the surface of CNTs
is properly functionalized (modiﬁed), a signiﬁcant improve-
ment in the cell and tissue compatibility can be achieved.
Another emerging issue of CNTs for use in biomedical areas
is to provide multifunctionality. One example of this is to
endow magnetic properties, which has been implemented
through the combination of magnetic nanoparticles (MNPs)
with CNTs.6−9 The MNP-decorated CNT (CNT@MNP) has
shown excellent magnetic properties, while preserving the
merits of CNTs, potentially extending the possible uses in cell
imaging and diagnostics associated with MNPs.10−12 Although
the speciﬁc performance of the CNT@MNP in medical ﬁelds
has not been elucidated, potential applications in therapeutics−
diagnostics (“theranostics”) are expected.
Therefore, here we ﬁrst focus on utilizing this CNT@MNP
more eﬃciently, through coating with silica. In particular, the
silica coating layer was developed to have a mesoporous
structure, aiming to improve drug loading and delivery capacity.
In fact, the silica (mesoporous or nonmesoporous) has been a
potent composition to cover relatively toxic nanomaterials, such
as quantum dots, CNTs and MNPs,13−15 creating a more
biocompatible interface in the interaction with cells and tissues.
One recent work has reported the decoration of CNTs with
magnetic silica nanoparticles.16
To the best of our knowledge, the development of
mesoporous silica-layered CNT@MNP (CNT@MNP@
mSiO2) has yet to be implemented. Here, we assess the
physicochemical and magnetic properties of CNT@MNP@
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mSiO2, and examine the capacity to enable imaging contrast
under a magnetic resonance in vitro and in vivo. Furthermore,
the potential of the nanomaterials in loading therapeutic
molecules is addressed using three model therapeutics,
cytochrome c, gentamicin, and small interfering RNA
(siRNA). Finally, the intracellular uptake of the siRNA-loaded
nanocarrier through a magnetofection is also investigated.
Scheme 1 depicts the synthesis scheme of CNT@MNP@
mSiO2 hybrid nanocarrier. First, amine-functionalized CNTs
were exposed to Fe2+ and Fe3+ solution which hydrolyzed into
β-FeOOH in neutral water (pH 7.0) at room temperature.
After this, uniform nanoparticles (β-FeOOH) are present on
the surfaces of CNTs templates, because β-FeOOH colloids
with a surface full of hydroxyl anion groups have a strong
propensity to electrostatically attract amino-modiﬁed CNT
molecules. In basic conditions, β-FeOOH transforms to Fe3O4
magnetite phase. Thereafter, a silica layer with a desired
thickness is deposited on the surface of the magnetite core and
CNTs by sol−gel polymerization of tetraethyl orthosilicate
(TEOS).
■ EXPERIMENTAL PROCEDURES
CNTs and Amination. CNTs (multiwalled, grade >95%
pure, 15−20 nm outer diameter, 10−20 μm length, EM-Power
Co., LTD, Korea,) were ﬁrst functionalized with carboxylic
group. One gram of raw CNTs was added to a 1:1 mixture of
concentrated nitric acid and/sulfuric acid and then reﬂuxed at
80 °C for 2 days. The carboxylated CNTs were then diluted
with distilled water and ﬁltered through a ﬁlter-paper
(Millipore, 0.2 μm polycarbonate). After the acid treatment
and ﬁltration processes, the size of CNTs decreased
substantially. The carboxylated CNTs were amine-function-
alized with 3-aminopropyltriethoxysilane (APTES, Sigma-
Aldrich) in the presence of 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide (EDC, Sigma-Aldrich). The aminated CNTs were
washed fully with distilled water and ethanol, and then dried
under vacuum for further uses.
Preparation of CNT@MNP and CNT@MNP@mSiO2.
Amine-functionalized CNTs (30 mg) were added either to
ferrous chloride tetrahydrate (FeCl2·4H2O, Sigma-Aldrich) in 1
M HCl or to ferric chloride hexahydrate (FeCl3·6H2O, Sigma-
Aldrich), which were then mixed (Fe2+/Fe3+ = 1/2) and
sonicated for 1 h. After this, the mixture was added dropwise
into 100 mL of 1.5 M NaOH solution with vigorous stirring.
After 30 min, the resulting precipitate was isolated by magnetic
ﬁeld and the solution was decanted after centrifugation at 8000
rpm and dried at 40 °C to prepare CNT decorated with MNPs
(CNT@MNP). All steps were performed under nitrogen gas to
avoid oxidation.
The CNT@MNP was covered with mesoporous silica via a
facile sol−gel coating pathway. The CNT@MNP (15 mg) was
added to the mixture solution of 200 mg of cetrimonium
bromide (CTAB, Sigma-Aldrich), 200 mL of ethanol, 20 mL of
distilled water, and 2.4 mL of ammonia (25%), and then
sonicated for 3 h. Silanization of CNT@MNP was carried out
by a dropwise addition of 200 μL of tetraethyl orthosilicate
(TEOS, Sigma-Aldrich) dissolved in 20 mL of ethanol while
stirring for 24 h. The solution was decanted and the CNT@
MNP ensheathed with silica were treated with 20 mg of
ammonium nitrate solution in 40 mL of deionized water at 60
°C overnight. After centrifugation, the samples were washed
with ethanol and distilled water, and then dried under vacuum
to obtain CNT@MNP@mSiO2.
The surface of CNT@MNP@mSiO2 was further amine-
functionalized with APTES for selective use of drug loading.
CNT@MNP@mSiO2 nanoparticles of 0.1 g of were added to
50 mL of toluene and sonicated for 30 min to a homogeneous
solution. One milliliter of APTES was added to this solution
and then reﬂuxed at 80 °C for 24 h, which was followed by a
centrifugation at 8000 rpm for 5 min and stringent washing
with toluene and ethanol. The product was dried in an oven at
80 °C for 24 h.
Characterizations. The crystal structure was determined
by X-ray diﬀraction (XRD; Ragaku). The samples were scanned
in the range of diﬀraction angle 2θ = 5−60° at a rate of 2°
min−1 with a step width of 0.02° 2θ using Cu Kα1 radiation at
40 kV and 40 mA. Fourier transform infrared spectroscopy
(FT-IR; Varian 640-IR) was used to determine chemical bond
status of the samples. For each spectrum, 20 scans in the
wavenumber of 400−2000 cm−1 were recorded in the
transmission mode by potassium bromide (KBr) pellet method.
The speciﬁc surface area was calculated by the Brunauer−
Emmett−Teller (BET) method. Pore size distribution was
measured from the Barret-Joner-Halenda (BJH) method. The
surface electrostatic property (ζ-potential) of the samples was
studied using a Zetasizer Nano apparatus (Malvern Instru-
ments) at pH 7.0 and 25 °C. The morphology of the samples
was characterized by transmission electron microscope (TEM,
JEOL-7100). The size of samples was analyzed by a particle size
analyzer (Zetasizer Nano ZS, Malvern Instruments, UK) based
on a dynamic light scattering (DLS) measurement.
Magnetic Properties and MRI Contrast Imaging. The
magnetic properties of the samples in powder form were
studied by superconducting quantum interference device
(SQUID, Quantum Design MPMS-XL7) in an applied
magnetic ﬁeld of ±20 kOe at room temperature. Magnetic
properties of the particles were evaluated in terms of saturation
magnetization and hysteresis loop area.
Magnetic resonance imaging (MRI) experiments of the
samples were performed at 25 °C in a clinical MR scanner
(BioSpec 47/40; Bruker; 4.7 T). CNT@MNP@mSiO2 hybrids
were suspended in tubes of water (1 mL) at iron concentration
of 0.0156, 0.0328, 0.0770, 0.1012, 0.1526, 0.2068, 0.3011 mM.
The tubes were placed into the MR scanner and a number of
MR sequence was run. T2 relaxation time was determined from
a spin−echo sequence (32 echoes, repetition time (TR) of
10000 ms, echo time (TE) of 7.5−256 ms, matrix size of 128 ×
128, slice thickness of 2 mm, ﬁeld of view of 50 × 60 mm2, and
Scheme 1. Schematic Illustration Showing the Synthesis of
Nanocarrier Mesoporous Magnetic Carbon Nanotubes
Ensheathed with Mesoporous Silica (CNT@MNP@mSiO2):
(a) CNT Serving As a Template, (b) Magnetite
Nanoparticles (MNP, red dots) Decorated on the CNT
Surface, and (c) Mesoporous Silica (mSiO2) Covering the
Surface of CNT@MNP
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number of acquisition of 1). Data were ﬁtted by using a
Levenberg−Marquardt method with Matlab (MathWorks Inc.)
and Origin (OriginLab Corp.) program.
Drug and Protein Loading. The loading of a series of
biomolecules onto the developed CNT@MNP@mSiO2 was
investigated. Two representative biomolecules, including
protein (cytochrome c; cyt C) and drug (gentamicin sulfate;
GS) were chosen. In each experiment, 1 mg of CNT@MNP@
mSiO2 was suspended in buﬀer solution (pH 7.4) with diﬀerent
concentration of the biomolecules, and ultrasonicated for 10 s
and left for 2 h at 37 °C. The equilibrated samples were
centrifuged for 4 min at 8000 rpm at each time point. The
amount of biomolecules adsorbed was calculated by subtracting
the amount remained in the supernatant liquid from the
amount initially added. For cyt C, ultraviolet−visible
spectrophotometer (Biochrom) was used to measure the
absorbance at 408 nm. In case of GS, o-phthaldialdehyde was
used as a derivatizing agent to react with the amino groups of
gentamicin and yield chromophoric products. The reaction was
carried out by making 1 mL of GS sample in solution react with
1 mL of isopropanol and 1 mL of o-phthaldialdehyde reagent.
After mixing, the concentration of GS was determined by the
UV absorbance at 332 nm.
siRNA Loading and Cell Uptake Study. For the loading
study of genetic molecules, small interfering RNA (siRNA) was
used. Diﬀerent concentration of CNT@MNP@mSiO2 (10, 20,
and 40 μg) were reacted with 1 μg of ﬂuorescein isothiocynate
(FITC)-conjugated negative control siRNA (Bioneer, Korea)
within 1 mL of release medium (RNase-free distilled water) for
60 min at room temperature. After the complexation reaction,
the release medium was centrifuged at 14 000 rpm and 4 °C for
30 min, and the amount of FITC-conjugated siRNA in the
supernatant was determined using a SpectraMax M2e multi-
detection microplate reader (Molecular Device). Samples were
tested in triplicate at each condition.
For the delivery of the siRNA-complexed CNT@MNP@
mSiO2 into cells, 2 μg of FITC-conjugated siRNA and 20 μg of
CNT@MNP@mSiO2 were mixed for 60 min, which was used
as a siRNA mixture. MC3T3-E1 (ATCC) cells were seeded at 1
× 105 cells in each well of six-well plates and the Opti-MEM
mixture (Invitrogen) was added to each well at a concentration
of 2 μg/mL and left for diﬀerent time points (from 10 to 120
min). In particular, magnetism-induced uptake test was also
carried out using a magnetofection kit as another experimental
group. After the cell uptake, the cells were harvested and
assessed. As a control group, siRNA (FITC-conjugated form)
only was also used, where the concentration was 2 μg, the same
as that used for the loading onto nanocarriers.
To quantify the population of siRNA-delivered cells, cells
were ﬁxed with 4% paraformaldehyde solution for 30 min on
the coating slide glass. The ﬁxed cells were washed with cold
PBS (4 °C) and mounted on a cover glass. Fluorescent images
were observed and analyzed using a LSM 510 laser-scanning
confocal microscope (Carl Zeiss). Cells were counterstained
with DAPI (Invitrogen) to observe the nuclei. Quantiﬁcation of
cell-uptake eﬃciency was also analyzed using a FACSCalibur
ﬂow cytometer (BD Biosciences). Data acquired for 10 000
cells in each sample were analyzed using the CellQuest Pro
software (BD Biosciences).
In Vivo Imaging Study. After conﬁrming the in vitro
images of samples, the in vivo study in mice was conducted. T2-
weighted MRI images were obtained using 4.7 T MRI system
(Bruker, Germany) under operating conditions (sequence value
TE/TR = 36/3500 ms, matrix size = 256 × 256, and ﬁeld of
view =35 × 35 mm2), before and after the injection of CNT@
MNP@mSiO2 nanocarriers. ICR mice (male, weight 25 g) were
Figure 1. TEM images of the (a) CNTs used as a template, (b) CNT decorated with MNPs (CNT@MNP), and (c) further ensheathed with
mesoporous silica (CNT@MNP@mSiO2). Inset images are low magniﬁcation. MNPs have sizes of ∼12 nm on average, and multiwalled CNTs have
a wall thickness of ∼14 nm and a total width of 35 nm. The outer silica was highly mesoporous, covering the MNP-decorated CNT surface
uniformly and completely. Average silica shell thickness was 18 nm. Arrows indicate silica shell and arrowheads point to embedded MNPs. (d) Image
of mSiO2-ensheathed CNT without MNP decoration, for the purpose of comparison. (e) DLS measured hydrodynamic size of the samples. (f) XRD
pattern of the mesoporous magnetic CNT, presenting peaks mainly of CNT (2θ = 25.5°), MNPs (2θ = 36, 38, 54, and 57°), and a broadened silica
peak at 2θ = 22.5°, demonstrating the coverage of CNT@MNP by the silica layer. (g) N2 adsorption/desorption isotherm curve of the mesoporous
magnetic CNT, in comparison with that of CNT@MNP without silica layering. (h) Characteristics of the mesopore structure, including mesopore
size, its volume and surface area, are also presented, comparing CNT@MNP and CNT@MNP@mSiO2.
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used under general anesthesia using 1% isoﬂurane gas.
Typically, the nanocarriers suspended in a physiological saline
at 500 μg/mL were administrated to ICR mice (25 g, 5 weeks
of age) through tail vein injection at a volume of 0.2 mL per
mice. The axial sections of the whole body of the mice were
imaged.
■ RESULTS AND DISCUSSION
First, the TEM image (Figure 1a) showed the typical
morphology of CNTs used as the template of the hybrid
nanocarriers, which revealed CNTs with lengths of submi-
crometers, the size range that has also been popularly
researched for cellular transportation.17−19 We further charac-
terized the CNT@MNP@mSiO2 hybrid nanocarriers. The
TEM images of CNT@MNP (Figure 1b) clearly showed a
number of spherical MNPs (size of 102 nm on average)
decorating the outer surface of the CNT. TEM images of
CNT@MNP@mSiO2 (Figure 1c) showed the mesoporous
silica shell (indicated as arrows) enclosing the CNT@MNP
with quite a uniform thickness. MNPs (darker dotted region,
arrowheads) present inside were also revealed. For the purpose
of comparison, CNT@mSiO2 produced free of MNPs is also
shown (Figure 1d). The hydrolysis of TEOS and subsequent
condensation reaction should occur by a heterogeneous
nucleation process. First, partially hydrolyzed TEOS molecules
adsorb onto the CNT@MNP surface, after which a
condensation reaction of neighboring silanol groups follows
to form siloxane networks under basic conditions (pH 10−
11).20 The thickness of the mSiO2 was measured to be 18 ± 5
nm. The hydrodynamic sizes of the nanocarriers were examined
by DLS measurement (Figure 1e). The sizes were 726, 752, and
846 nm for CNT, CNT@MNP, and CNT@MNP@mSiO2,
respectively, and the values are considered to reﬂect the length
of nanotubes. This dimensional range (submicrometers, < 1
μm) has also been reported elsewhere for CNTs and their
hybrids developed for the use as drug delivery and imaging
Figure 2. Magnetic properties of the CNT@MNP@mSiO2 hybrid, showing magnetization as a function of magnetic ﬁeld applied in range −20k Oe
to 20k Oe, as measured by SQUID magnetization measurement. CNT@MNP without silica layering is also presented for comparison. Inset shows
the samples being attracted to a magnet for CNT@MNP@mSiO2. (b) Graph in the narrow magnetic ﬁeld range, and (c) saturation magnetization,
Ms, and coercive force, Hc, of the samples calculated from the graphs. (d) T2-weighted images of CNT@MNP@mSiO2 samples measured by a
clinical 4.7T MR system, showing remarkable change in signal intensity depending on Fe concentration (numbered in each image), and (e) plotting
of 1/T2 with respect to Fe concentration, showing a linear relationship with R2 relaxivity of 155.8 Fe mM
−1s−1. (f) In vivo T2-weighted MRI images
of liver (left) and kidney and spleen (right) before and after intravenous administration of CNT@MNP@mSiO2 nanocarriers. 0.2 mL of sample
solution prepared in a physiological saline at a concentration of 500 μg/mL was administered to 25 g mouse.
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systems, suggesting their usefulness in biomedical applica-
tions.21−23 The phase of the products was analyzed by XRD
(Figure 1f). XRD of pure CNT showed three peaks at 2θ =
25.99, 42.94, and 53.63°, characteristic of a graphite structure,
and that of CNT@MNP gave additional peaks which were
those of ferrite. The size of MNP calculated from the (311)
peak in the XRD pattern using Scherrer’s equation resulted in
10.6 nm, which corresponds well to the TEM image.24 The
XRD pattern of CNT@MNP@mSiO2 showed a broad peak at
2θ ≈ 22°, conﬁrming the amorphous sate of SiO2.
FT-IR analysis of the nanomaterials was also carried out (see
Figure S1a in the Supporting Information). IR spectrum of the
CNT showed the bands at 1633 and 1586 cm−1, which were
attributed to amide carbonyl and N−H in plane stretching, and
that of CNT@MNP presented a strong band at 600−560 cm−1,
characterizing Fe−O vibration related to the magnetic core
particles.15 The IR spectrum of CNT@MNP@mSiO2 revealed
bands associated with the Si structure (Si−O−Si asymmetric
stretching at 1073 cm−1, Si−O−Si symmetric vibration at 806
cm−1 and Si−OH stretching at 953 cm−1, and bending at 463
cm−1). The mSiO2-covered CNT@MNP exhibited a highly
negative zeta-potential (−43.6 mV), which is ascribed to the
presence of a bunch of hydroxyl groups (see Figure S1b in the
Supporting Information). When the CNT@MNP@mSiO2
hybrid was functionalized with amine group, the zeta-potential
dramatically changed to a highly positive value, +33.7 mV. This
switchable charge characteristic of the CNT@MNP@mSiO2
hybrid nanocarrier, aﬀorded by a simple surface treatment,
should allow for the versatile loading of biomolecules in a broad
range, from negative- to positive-charged biomolecules,
thorough charge−charge interaction. The eﬀects of mSiO2 on
mesoporosity were further characterized (Figure 1g). The
nitrogen adsorption/desorption isotherm curve of the CNT@
MNP@mSiO2 hybrid represents a behavior typical of a
mesoporous material, with a sharp upturn in the high relative
pressure region, which was not readily observed in the CNT@
MNP without mesoporous silica coating. The average pore size
(PS), speciﬁc pore volume (SPV) and speciﬁc surface area
(SSA) values are also presented (Figure 1h). The generated
mesopores in the CNT@MNP@mSiO2 hybrid nanocarrier
showed an average size of 3.67 nm. The SPV and SSA values
for CNT@MNP@mSiO2 were signiﬁcantly enhanced, com-
pared to those for CNT@MNP; 0.024 vs 0.23 cm3/g in SPV,
and 24.61 vs 66.68 m2/g in SSA; whereas the surface area
increase was only 3 times, the pore volume increase was as high
as ∼10 times. The BET results indicate that the mesoporous
silica coating endowed the magnetic CNTs with a high level of
mesoporosity, which will provide great potential for loading
small therapeutic molecules.
Along with the physicochemical properties, the magnetic
properties of the CNT@MNP@mSiO2 hybrid were charac-
terized using SQUID magnetometry. Figure 2 shows the room-
temperature magnetization hysteresis loops of the CNT@MNP
and CNT@MNP@mSiO2 with respect to the magnetic ﬁeld
applied (−20 kOe to 20 kOe in Figure 2a and the narrower
range −80 to 80 Oe in Figure 2b). On the basis of these
hysteresis loops, the magnetization behavior of both nanoma-
terials demonstrated ferromagnetic properties (i.e., a narrow
hysteresis loop and low coercivity),15,25 identical to those of
pure MNP. The saturation magnetization (Ms) and coercive
force (Hc) were obtained from the curves (Figure 2c). The Ms
of CNT@MNP is 46.3 emu/g, smaller that of bulk MNP (94
emu/g26), which can be attributed to the existence of CNTs,
i.e., the reduced mass fraction of magnetite crystallites and the
possible strain between the magnetite nanoparticles and the
CNT surface.27 With the mesoporous silica coating, the Ms
value decreased to 27.1 emu/g, which is due to the shielding
eﬀect of silica layer of the MNPs as well as the reduction in
mass fraction of MNPs. The Hc values of CNT@MNP and
CNT@MNP@mSiO2 were determined to be comparable.
Although the magnetic properties of the CNT@MNP@
mSiO2 hybrid were reduced with respect to those of pure
magnetite nanoparticles, the hysteresis behaviors were charac-
teristic of ferromagnetic materials, and the Ms and hysteresis
loop area still exhibited high levels.
We further determined whether CNT@MNP@mSiO2
hybrid nanocarrier could be used as a contrast agent in
magnetic resonance imaging (MRI). Diﬀerent amount of the
hybrid was dispersed in water solution (which thus containing
varying Fe concentration, as determined by ICP-AES), and the
image contrast was measured by a clinical 4.7T MR system at
room temperature. As the superparamagnetic characteristics of
the MNP nanocrystals accelerate the transverse relaxation of
water protons, the CNT@MNP@mSiO2 hybrid is considered
to be used as a T2 contrast agent in MRI. The T2-weighted
images of the samples revealed remarkable change in signal
intensity depending on the Fe concentration (Figure 2d).
Meanwhile, the transverse relaxivity R2 (1/T2) measured on the
samples was shown to have a linearity with increasing Fe
concentration (Figure 2e), indicating that CNT@MNP@
mSiO2 hybrid generated MRI contrast on T2 weighted spin−
echo sequence. The transverse relaxivity R2 of CNT@MNP@
mSiO2 hybrid was calculated to be 155.8 Fe mM
−1s−1, which
was comparable to the literature values,28−31 particularly to
those of CNT/MNP hybrids without the mesoporous silica
layer. Wu et al. developed CNT/MNP system for T2-contrast
agents, and they reported the R2 relaxivity of 175.5 Fe mM
−1
s−1.29 Lamanna et al. also produced CNT/MNP hybrids and
showed the R2 value of 103 Fe mM
−1 s−1.30 The relaxivity of
CNT/MNP system also depends on size and relative mass of
MNPs, with the highest R2 value of 110 Fe mM
−1s−1 reported
by Jang et al.31 Therefore, the in vitro results shown herein
suggest that CNT@MNP@mSiO2 hybrid nanocarrier can be
used as a favorable T2 contrast agent. On the other hand, the
longitudinal relaxivity R1 of the CNT@MNP@mSiO2 hybrid
nanocarrier was measured to be 5.92 Fe mM−1 s−1, a value
much lower than R2 value, as have also been reported elsewhere
on the MNP/CNTs,30,32 implying the currently developed
nanocarrier would be more proper use as T2 contrast agent.
The results on magnetization hysteresis loop behavior and
the MRI contrast image allow us to consider choosing the
multifunctional nanocarriers for the applications of magnetism-
related ﬁelds, such as hyperthermia thermoseed for cancer
treatment, magnetic resonance diagnostics, stem cell separation
and imaging, and remotely controlled magnetic drug
delivery.33,34 Among else, we investigated the possibility of
the developed CNT@MNP@mSiO2 nanocarriers for the in
vivo MRI applications. The in vivo contrast-enhancing eﬀect of
the nanocarriers was evaluated in ICR mice with the 4.7 T MRI
system. The T2-weighted MRI images of mouse liver and
kidneys and spleen before and after the administration of
samples are presented (Figure 2f). After intravenous injection,
the liver was darkened signiﬁcantly in comparison with those
without administration, but less obvious attenuation was
observed for both kidney and spleen (indicated as arrows),
showing a similar result to other reports where CNT/MNP was
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used.29 The in vivo results suggest that the developed hybrid
nanocarriers can act as a suitable negative (T2) contrast agent in
MRI applications.
As another possible utility of the developed CNT@MNP@
mSiO2 hybrid nanocarrier, we here investigated the feasibility in
loading therapeutic molecules and delivering them within cells
through an intracellular penetration. Furthermore, for the
loading study, we used three model biomolecules. As a model
protein, cyt C was chosen, which is positive-charged and
relatively small, compared to other proteins (molecular
dimensions, 2.6 nm × 3.2 nm × 3.0 nm; and molecular weight,
886.90).35 As a model small drug, gentamicin (the sulfated
form) was selected, which is a hydrophilic antibiotic (molecular
dimensions: 0.52 × 1.53 nm and molecular weight: 575.69).36
Moreover, siRNA was chosen as a model nucleic acid, which is
highly negatively charged and a relatively small nucleic acid
(∼20 base pair). For the loading experiments, the charge−
charge interactions between candidate molecules and meso-
porous silica were considered, and thus, the as-layered mSiO2
was used for both gentamicin and cyt C, whereas aminated-
mSiO2 was introduced for siRNA.
The capacity of the developed CNT@MNP@mSiO2 hybrid
for loading the model molecules was investigated. Figure 3
shows the loaded amount of gentamicin or cyt C within the
CNT@MNP@mSiO2, as a function of the initial amount of
model molecules used, and magnetic CNTs without mSiO2
were compared. For both types of molecules, the saturated
loading amount was signiﬁcantly higher in CNT@MNP@
mSiO2 than in CNT@MNP; for gentamicin 0.27 vs 0.07 mg
and for cyt C 0.11 vs 0.03 mg, showing approximately 4-fold
increase in the loading capacity. Results clearly demonstrated
the eﬀective role of the mesoporous silica present on the
Figure 3. Loading capacity of therapeutic molecules onto the magnetic CNT due to the coverage of mesoporous silica; model biomolecules,
including (a) gentamicin and (b) cyt C showed signiﬁcant higher loading amount in CNT@MNP@mSiO2 vs CNT-MNP.
Figure 4. siRNA loading and cellular uptake study of the mesoporous magnetic CNT. (a) siRNA loaded amount with respect to varying quantity of
the CNT@MNP@mSiO2 nanocarriers (10, 20, and 40 μg used for each 1 μg of siRNA), showing an almost complete saturation at 20 μg. (b) Cell
images taken by CLSM, ﬂuorescence signals revealed for nuclei (blue, DAPI), siRNA-nanocarrier complex (green, FITC-conjugation to siRNA), and
merged one. (c) Uptake eﬃciency measured by FACS analysis. Cellular uptake with or without magnet was carried out at varying time points, and
cells positive for FITC signals were ﬂuorescence-sorted. Free siRNA was used as a control. (d) Quantiﬁed graph of the uptake eﬃciency.
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surface, in taking up model molecules within the mesopore
structure. Gentamicin loading was much higher than cyt C
loading, particularly on the CNT@MNP@mSiO2 nanocarriers,
which reﬂects the size eﬀect of the molecules, i.e., smaller-sized
gentamicin molecules are loaded to a greater degree within the
mesopores of the silica.
For the loading of siRNA, we aminated the CNT@MNP@
mSiO2 samples to allow charge−charge interaction. In fact, the
loading of siRNA onto the nonaminated CNT@MNP@mSiO2
was found to be negligible. However, the aminated CNT@
MNP@mSiO2 clearly showed the incorporation of siRNA
molecules (as shown in Figure 4a), signifying the importance of
surface charges to eﬀectively load nucleic acids. The amount of
siRNA loaded was measured by a nanodrop method, by varying
the quantity of CNT@MNP@mSiO2 added initially (10, 20,
and 40 μg) within the medium containing 1 μg of siRNA.
Results indicated that almost complete saturation occurred
through loading onto 20 μg of nanocarriers with approximately
0.6 μg saturated siRNA.
After conﬁrming the siRNA loading onto the developed
nanocarriers, we next sought to determine whether the siRNA-
nanocarrier complex can be eﬀectively delivered into tissue
cells. Prior to this, we performed a cytotoxicity test to screen
the doses of nanocarriers that are toxic to the cells. MC3T3-E1
cells were treated with the nanocarriers at varying doses (1 μg
to 100 μg/mL) and the cell viability was measured at 24 h.
Results gave dose-dependent cytotoxicity at doses largely above
10 μg/mL, below which the cells were almost intact (viability
over 95% of blank control) (see Figure S2 in the Supporting
Information). On the basis of this, we applied the dose of 10
μg/mL nanocarriers for the cellular uptake study. In particular,
we designed a cell uptake study using a magnet, as the
nanocarriers feature ferromagnetic properties. The cellular
uptake of the siRNA-nanocarrier complex was visualized under
a confocal microscope after FITC was conjugated to siRNA.
Whereas the cells without siRNA loading did not show any
ﬂuorescence signals, those loaded with siRNA revealed strong
green FITC-signals within the cytoplasm (Figure 4b). The cell-
uptake eﬃciency of the siRNA-nanocarrier complex was
analyzed by FACS (Figure 4c). Cells were treated either with
siRNA only, or with the siRNA-nanocarrier complex, with or
without the use of magnetism for diﬀerent durations (5, 10, 20,
30, and 120 min). FACS histograms showed that large cell
populations became positive for FITC-signals when treated
with the siRNA-nanocarrier complex, which was not readily
observed in the case of being treated with siRNA only. The cell-
uptake eﬃciency of the delivery system was as high as ∼72% at
5 min and ∼80% at 120 min, even without the use of
magnetism, which was further increased to 90−93% through
the period when magnetism was introduced (Figure 4d).
Results demonstrated the eﬀectiveness of the developed
CNT@MNP@mSiO2 nanocarrier system in penetrating the
cell membrane. Although the enhancement in the cellular
uptake by the magnetism was not so big, the eﬀect was also
noticed, suggesting the role of MNPs embedded in the hybrid
nanocarrier.
In fact, the cellular uptake of CNTs with nanotubular
morphology has been conﬁrmed in a range of studies.37−40
Because of their needlelike shapes, CNTs are able to perforate
cellular membrane and pass into the intracellular components
very easily without causing apparent cell damage.37−40 This is
one merit of the currently developed CNT@MNP@mSiO2
nanocarrier system with a nanotubular geometry that was
enabled by CNTs. In fact, because of the unique properties of
CNTs, their biomedical applications have gained great
attention, and particularly when developed to have multi-
functionality, such as magnetism for diagnostics and meso-
porosity for drug delivery, their potential for use in theranostics
should be greatly improved. Here we demonstrated these
aspects of CNTs with hybridization of MNPs and mSiO2.
Future studies remain as to the speciﬁc applications of the
developed nanocarriers, such as tissue repair and disease
treatment, where the drug delivery and imaging capacities are
on highly demand.
■ CONCLUSIONS
In summary, we present a straightforward synthesis method of
mesoporous magnetic CNT, CNT@MNP@mSiO2. The nano-
material showed a high mesoporosity due to the surface-layered
mSiO2, and excellent magnetic properties, retaining the
characteristics of magnetite nanoparticles within the structure
as revealed in vitro and in vivo. Investigation of the loading
capacity of therapeutic molecules and their intracellular delivery
demonstrated the mesoporous and magnetic nanocarriers
showed high loading capacity for biological molecules,
including gentamicin, cyt C, and siRNA, and allowed for a
high cellular uptake rate through magnetism, while eliciting
minimal toxicity to cells. This novel multifunctional nanocarrier
may be potentially applicable as theranostic systems.
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